Alexander Tkachenko
Chief Executive Officer bij Epiodyne, Inc.
Profiel
Alexander Tkachenko is the founder of Siluria Technologies, Inc. which was founded in 2008.
He was the President & Director from 2010 to 2013.
Currently, he is the Chief Executive Officer & Director at Epiodyne, Inc. and an Executive at EcoR1 Capital, LLC.
Previously, he was the Chief Executive Officer at BlackThorn Therapeutics, Inc., an Associate Director at Genentech, Inc., and the VP-Corporate Development & Strategic Planning at Talon Therapeutics, Inc. He also served as a Squad Leader in the Armed Forces of the Russian Federation.
Dr. Tkachenko holds a doctorate from the University of Medicine & Dentistry of New Jersey and an MBA from Harvard Business School.
Actieve functies van Alexander Tkachenko
| Bedrijven | Functie | Begin |
|---|---|---|
Epiodyne, Inc.
 Epiodyne, Inc. Pharmaceuticals: MajorHealth Technology Epiodyne, Inc. engages in biotechnology services. The company was founded by Brian Shoichet, Brian Kobilka, Peter Gmeiner, Bryan L. Roth, Gregory Scherrer, and Aashish Manglik in 2016 and is headquartered in San Francisco, CA. | Chief Executive Officer | - |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Private Equity Investor | - |
Eerdere bekende functies van Alexander Tkachenko
| Bedrijven | Functie | Einde |
|---|---|---|
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Chief Executive Officer | 07-02-2017 |
| Armed Forces of the Russian Federation | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Siluria Technologies, Inc.
 Siluria Technologies, Inc. Chemicals: SpecialtyProcess Industries Siluria Technologies, Inc. develops and manufactures a direct chemical process for plastics and fuels from natural gas. Its second process technology can convert ethylene to liquid fuels such as gasoline, diesel or jet fuel. The firm’s revolutionary catalyst technologies uniquely combine nanomaterials, biotechnology and chemical engineering, to convert an abundant, ubiquitous, and inexpensive feedstock into high value, drop-in fuels and chemicals using processes that can be seamlessly integrated into existing industry infrastructure. The company was founded by Clinton Whitewood Bybee and Alexander Tkachenko in 2007 and is headquartered in San Francisco, CA. | Founder | - |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | - |
Opleiding van Alexander Tkachenko
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Siluria Technologies, Inc.
Siluria Technologies, Inc. Chemicals: SpecialtyProcess Industries Siluria Technologies, Inc. develops and manufactures a direct chemical process for plastics and fuels from natural gas. Its second process technology can convert ethylene to liquid fuels such as gasoline, diesel or jet fuel. The firm’s revolutionary catalyst technologies uniquely combine nanomaterials, biotechnology and chemical engineering, to convert an abundant, ubiquitous, and inexpensive feedstock into high value, drop-in fuels and chemicals using processes that can be seamlessly integrated into existing industry infrastructure. The company was founded by Clinton Whitewood Bybee and Alexander Tkachenko in 2007 and is headquartered in San Francisco, CA. | Process Industries |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
| Armed Forces of the Russian Federation | |
EcoR1 Capital, LLC
EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Finance |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Health Technology |
Epiodyne, Inc.
Epiodyne, Inc. Pharmaceuticals: MajorHealth Technology Epiodyne, Inc. engages in biotechnology services. The company was founded by Brian Shoichet, Brian Kobilka, Peter Gmeiner, Bryan L. Roth, Gregory Scherrer, and Aashish Manglik in 2016 and is headquartered in San Francisco, CA. | Health Technology |
